InsiderSource
TXG

10x Genomics, Inc.

SEC CIK 1770787
$29.05 +50.7% · 90 days
90-day buys
$0
0 open-market
90-day sells
$1.77M
7 open-market
Net insider flow
−$1.77M
Net selling
Filings shown
29
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at TXG have sold a net $1.77M of stock (0 open-market buys vs 7 sells).

Largest recent trade: Saxonov Serge sold $444.2K of TXG, trimming their stake 2%.

Most active filer: Saxonov Serge, with 14 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for TXG, newest first
View on SEC EDGAR ↗
Advertisement
TXG
10x Genomics, Inc.
Sell Saxonov Serge · Director, Chief Executive Officer · Open-market sale · filed 2w ago ΔOwn −0.9%

Saxonov Serge sold $264.8K of TXG, trimming their stake 1%.

−$264.8K
10,718 sh @ $25
TXG
10x Genomics, Inc.
Sell Saxonov Serge · Director, Chief Executive Officer · Open-market sale · filed 2w ago ΔOwn −1.6%

Saxonov Serge sold $444.2K of TXG, trimming their stake 2%.

−$444.2K
18,175 sh @ $24
TXG
10x Genomics, Inc.
Sell Hindson Benjamin J. · Director, See Remarks · Open-market sale · filed 2w ago ΔOwn −2.3%

Hindson Benjamin J. sold $283.4K of TXG, trimming their stake 2%.

−$283.4K
11,595 sh @ $24
TXG
10x Genomics, Inc.
Sell Taich Adam · Chief Financial Officer · Open-market sale · filed 2w ago ΔOwn −3.8%

Taich Adam sold $369K of TXG, trimming their stake 4%.

−$369K
15,098 sh @ $24
TXG
10x Genomics, Inc.
Sell Saxonov Serge · Director, Chief Executive Officer · Open-market sale · filed Apr 16, 2026 ΔOwn −0.4%

Saxonov Serge sold $122.8K of TXG.

−$122.8K
5,000 sh @ $25
TXG
10x Genomics, Inc.
Sell Saxonov Serge · Director, Chief Executive Officer · Open-market sale · filed Mar 25, 2026 ΔOwn −0.4%

Saxonov Serge sold $97.6K of TXG.

−$97.6K
5,000 sh @ $20
TXG
10x Genomics, Inc.
Sell Saxonov Serge · Director, Chief Executive Officer · Open-market sale · filed Mar 25, 2026 ΔOwn −0.8%

Saxonov Serge sold $191.3K of TXG, trimming their stake 1%.

−$191.3K
10,000 sh @ $19
TXG
10x Genomics, Inc.
Sell Saxonov Serge · Director, Chief Executive Officer · Open-market sale · filed Mar 4, 2026 ΔOwn −1.2%

Saxonov Serge sold $324K of TXG, trimming their stake 1%.

−$324K
14,292 sh @ $23
TXG
10x Genomics, Inc.
Sell Saxonov Serge · Director, Chief Executive Officer · Open-market sale · filed Mar 4, 2026 ΔOwn −0.2%

Saxonov Serge sold $43.1K of TXG.

−$43.1K
1,860 sh @ $23
TXG
10x Genomics, Inc.
Sell Teichmann Sarah A. · Director · Open-market sale · filed Feb 27, 2026 ΔOwn −22%

Teichmann Sarah A. sold $147.1K of TXG, trimming their stake 22%.

−$147.1K
7,579 sh @ $19
TXG
10x Genomics, Inc.
Sell Saxonov Serge · Director, Chief Executive Officer · Open-market sale · filed Feb 25, 2026 ΔOwn −0.9%

Saxonov Serge sold $178.9K of TXG, trimming their stake 1%.

−$178.9K
9,632 sh @ $19
TXG
10x Genomics, Inc.
Sell Taich Adam · Chief Financial Officer · Open-market sale · filed Feb 25, 2026 ΔOwn −3.0%

Taich Adam sold $166.6K of TXG, trimming their stake 3%.

−$166.6K
8,968 sh @ $19
TXG
10x Genomics, Inc.
Sell Hindson Benjamin J. · Director, See Remarks · Open-market sale · filed Feb 25, 2026 ΔOwn −1.8%

Hindson Benjamin J. sold $145.4K of TXG, trimming their stake 2%.

−$145.4K
7,826 sh @ $19
TXG
10x Genomics, Inc.
Option exercise Saxonov Serge · Director, Chief Executive Officer · Option exercise · filed Jan 7, 2026 ΔOwn +4.9%
+$60K
50,000 sh @ $1
TXG
10x Genomics, Inc.
Sell Taich Adam · Chief Financial Officer · Open-market sale · filed Nov 25, 2025 ΔOwn −3.8%

Taich Adam sold $225.9K of TXG, trimming their stake 4%.

−$225.9K
11,888 sh @ $19
TXG
10x Genomics, Inc.
Sell Hindson Benjamin J. · Director, See Remarks · Open-market sale · filed Nov 25, 2025 ΔOwn −1.9%

Hindson Benjamin J. sold $157.4K of TXG, trimming their stake 2%.

−$157.4K
8,283 sh @ $19
TXG
10x Genomics, Inc.
Sell Saxonov Serge · Director, Chief Executive Officer · Open-market sale · filed Nov 25, 2025 ΔOwn −1.3%

Saxonov Serge sold $251.9K of TXG, trimming their stake 1%.

−$251.9K
13,261 sh @ $19
TXG
10x Genomics, Inc.
Sell Saxonov Serge · Director, Chief Executive Officer · Open-market sale · filed Aug 26, 2025 ΔOwn −1.0%

Saxonov Serge sold $128.9K of TXG, trimming their stake 1%.

−$128.9K
9,348 sh @ $14
Advertisement

About TXG insider activity

This page tracks every recent Form 4 filed for 10x Genomics, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is TXG insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for 10x Genomics, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.